CGT

830개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved830 programs
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART22-65s cells (CART22-65s cells)

Chemotherapy Resistant Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleKecellitics Biotech Company LtdPhase 2

CD19 and CD22 targeted CAR-T cells (CD19 and CD22 targeted CAR-T cells)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 3Status Active
CGTLimited DatastaleInnovative Cellular Therapeutic…Preclinical

CD19CART (CD19CART)

Leukemia, B-Cell; Lymphoma, B-Cell · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 3Status Active
CGTLimited DatastaleBeijing BiotechPhase 1

CD20/BCMA-directed CAR-T cells (CD20/BCMA-directed CAR-T cells)

Systemic Lupus Erythematosus (SLE); Immune-mediated Necrotizing Myopathy (IMNM) · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleThe Leukemia and Lymphoma Socie…Phase 1

CD22CART infusion (CD22CART infusion)

Leukemia; Acute Lymphoblastic Leukemia · CD22

#CD22#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

CD30.CAR-EBVST cells (CD30.CAR-EBVST cells)

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type; Classical Hodgkin Lymphoma · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 3Status Discontinued
CGTLimited DatastaleBeijing BiotechPhase 2

EB-DT-CAR-NK (EB-DT-CAR-NK)

Advanced Gastric Adenocarcinoma; Advanced Gastroesophageal Junction Adenocarcinoma · Advanced Gastric Adenocarcinoma

#AdvancedGastricAdenocarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 3Status Recruiting
CGTStandard DatabasestaleImmunityBio, Inc.Phase 2

PSA-based Oncolytic Virus (ETBX-071, ETBX-071 (PSA-based Oncolytic Virus))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 3Status Discontinued
CGTLimited DatastaleNanjing IASO Biotechnology Co.,…Phase 2

Eque-cel CAR-T Therapy (Eque-cel CAR-T Therapy)

AL Amyloidosis · AL Amyloidosis

#ALAmyloidosis#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 3Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 2

Humanized CD7 CAR-T cells (Humanized CD7 CAR-T cells)

Refractory and Relapsed T Cell Lymphoma · T Lymphoblastic Leukemia/Lymphoma

#TLymphoblasticLeukemiaLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleJuno Therapeutics, a Subsidiary…Preclinical

JCAR015 (JCAR015)

Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 3Status Active
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

LCAR-AIO T cells (LCAR-AIO T cells)

Multiple Sclerosis (MS); Neuromyelitis Optica Spectrum Disease (NMOSD) · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Discontinued
CGTLimited DatastaleMiltenyi Biomedicine GmbHPhase 1

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Primary Central Nervous System (CNS) Lymphoma; Secondary Central Nervous System Lymphoma · Primary Central Nervous System (CNS) Lym

#PrimaryCentralNervousSystemCNSLy#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Recruiting
CGTLimited DatastaleStephan Grupp MD PhDPhase 2

Murine CART19 (Murine CART19)

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL; Infants With Very High Risk KMT2A B-ALL · Pediatric and Young Adult Patientswith H

#PediatricandYoungAdultPatientswi#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleWuhan Sian Medical Technology C…Phase 1

Second generation humanized CAR-T cells (Second generation humanized CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleHrain Biotechnology Co., Ltd.Phase 1

anti-meso-CAR vector transduced T cells (anti-meso-CAR vector transduced T cells)

Malignant Mesothelioma; Pancreatic Cancer · Malignant Mesothelioma

#MalignantMesothelioma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastalePediatric Brain Tumor ConsortiumPhase 1

oncolytic HSV-1716 (oncolytic HSV-1716)

Recurrent Childhood Anaplastic Astrocytoma; Recurrent Childhood Anaplastic Oligoastrocytoma · Recurrent Childhood Anaplastic Astrocyto

#RecurrentChildhoodAnaplasticAstr#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Discontinued
CGTLimited DatastaleBaylor College of MedicinePhase 1

21.15.GPC3-CAR T cells (21.15.GPC3-CAR T cells)

Hepatoblastoma; Hepatocellular Carcinoma · Hepatoblastoma

#Hepatoblastoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTAAVLimited DatastaleAdrenas Therapeutics IncPhase 2

AAV BBP-631 (AAV BBP-631)

Congenital Adrenal Hyperplasia · Congenital Adrenal Hyperplasia

#CongenitalAdrenalHyperplasia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting

12 / 42 pages

← PreviousNext →